Clin Osteol 2018; 23(3): 126-131

Vertebral compression fractures in pediatric patients with Crohn´s disease: case reportsCase reports

Čagalová Alžbeta1, Čierna Iveta1, Tichá Ľubica1, Trepáč Martin2, Podracká Ľudmila1
1 Detská klinika LF UK a Národný ústav detských chorôb, Bratislava
2 Ortopedická klinika LF UK a Národný ústav detských chorôb, Bratislava

Alterations in bone metabolism are a common complication of inflammatory bowel disease. In pediatric patients, the changes present themselves as growth retardation, decrese in bones mass with changes of its microstructure. Pathological changes can be seen already at the time of diagnosis of primary disease. Pathogenesis of bone loss is multifactorial. Symptoms of skeletal involvement include severe bone pain, backache, kyphosis and fractures. In the article, we present two interesting case reports of adolescents with osteoporosis and vertebral compression fractures that have been manifested during Crohn's disease.

Keywords: body mass index; Crohn's disease; vertebral compression fractures

Received: October 17, 2018; Accepted: November 6, 2018; Published: December 11, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čagalová A, Čierna I, Tichá Ľ, Trepáč M, Podracká Ľ. Vertebral compression fractures in pediatric patients with Crohn´s disease: case reports. Clinical Osteology. 2018;23(3):126-131.
Download citation

References

  1. Greer FR, Krebs NF. [American Academy of Pediatrics Committee on Nutrition].Optimizing bone health and calcium intakes of infants, children, and adolescents. Pediatrics 2006; 117(2): 578-585. Dostupné z DOI: <http://doi10.1542/peds.2005-2822>. Go to original source...
  2. Laakso S, Valta H, Verkasalo M et al. Compromised peak bone mass in patients with inflammatory bowel disease -⁠ a prospective study. J Pediatr 2014; 164(4): 1436-1443. Dostupné z DOI: <http://doi10.1016/j.jpeds.2014.01.073>. Go to original source...
  3. Gilbert L, He X, Farmer P, et al. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 2000; 141(11): 3956-3964. Dostupné z DOI: <http://doi10.1210/endo.141.11.7739>. Go to original source...
  4. Ward LM. Osteoporosis due to glucocorticoid use in children with chronic illness. Horm Res 2005; 64(5): 209-221. Dostupné z DOI: <http://doi10.1159/000088976>. Go to original source...
  5. Hildebrand H, Karlberg J, Kristiansson B. Longitudinal growth in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1994; 18(2): 165-173. Go to original source...
  6. Kappelman MD, Galako JA, Porter CQ et al. The Risk of Diagnosed Fractures in Children with Inflammatory Bowel Diseases. Inflamm Bowel Dis 2011; 17(5): 1125-1130. Dostupné z DOI: <http://doi10.1002/ibd.21472>. Go to original source...
  7. Ahmed SF, Horrocks IA, Patterson T et al. Bone mineral assessment by dual energy X-ray absorptiometry in children with inflammatory bowel disease: evaluation by age or bone area. J Pediatr Gastroenterol Nutr 2004; 38(3): 276-280. Go to original source...
  8. Thearle M, Horlick M, Bilezikian JP et al. Osteoporosis: An anusual presentation of childhood Crohn's disease. J Clin Endocrinol Metab 2000; 85(6): 2122-2126. Dostupné z DOI: <http://doi10.1210/jcem.85.6.6640>. Go to original source...
  9. Patschan D, Loddenkemper K, Buttgereit F. Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone 2001; 29(6): 498-505. Go to original source...
  10. Tichá Ľ, Payer J, Killinger Z et al. Kostný metabolizmus u pacientok s mentálnou anorexiou. Osteologický bulletín 2016; 21(2): 73-74.
  11. Wong SCh, Catto-Smith AGA, Zacharin M. Pathological fractures in paediatric patients with inflammatory bowel disease. Eur J Pediatr 2014; 173 (2): 141-151. Dostupné z DOI: <http://doi10.1007/s00431-013-2174-5>. Go to original source...
  12. Payer J, Killinger Z. Osteoporóza. Herba: Bratislava 2012. ISBN 978-80-89171-94-1.
  13. Pappa H, Thayu M, Sylvester F et al. Skeletal health of children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011; 53(1): 11-25. Dostupné z DOI: <http://doi10.1097/MPG.0b013e31821988a3>. Go to original source...




Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.